Interestingly, 4 new unexpected PTs (cardiac failure, pericardial effusion, cardiac tamponade, and cardiomyopathy) also had positive signals in a previous pharmacovigilance study that focused on the ALK-TKI-associated cardiotoxicity (Liu et al., 2022). This evidence concerns the gene ALK and cardiomyopathy.